Ampere Aadi

Wednesday, 30 October 2024 10:50 AM Aadi Bioscience, Inc. announced that it will report its third-quarter 2024 financial results and provide recent corporate updates on November 6, 2024. The company is focused on the commercialization of FYARRO® for treating adult patients with locally advanced unresectable or metastatic malignant perivascular epithelioid cell tumor (PEComa). I think this could be a significant step forward in precision oncology.

Thursday, 16 May 2024 10:54 AM Ampere Computing announced its 2024 strategy and roadmap, highlighting significant advancements in sustainable and power-efficient computing for cloud and AI applications. The company unveiled its flagship product, AmpereOne, which includes a new 256-core CPU that outperforms other market CPUs by over 40%. This new product line focuses on high-efficiency performance, memory, cache, and AI computing capabilities.

Thursday, 16 May 2024 07:12 PM Ampere Computing has been at the forefront of reducing power consumption while increasing performance, offering up to 2-3 times the performance of traditional CPUs. The companys focus on sustainability and efficiency is set to lead the data center industry towards a more efficient and sustainable future. I believe this approach will be crucial as the demand for computing power continues to grow.